Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city

References

• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Katabira, E. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. doi: 10.1056/NEJMoa1108524
   PubMed Web of Science ®Google Scholar
• Baeten, J., Palanee-Phillips, T., & Brown, E. (2016). A phase III trial of the dapivirine vaginal ring for HIV-1 prevention in women. Paper presented at the Program and abstracts of the 2016 Conference on Retroviruses and Opportunistic Infections.
   Google Scholar
• Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., … Hillier, S. (2016). Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. New England Journal of Medicine, doi: 10.1056/NEJMoa1506110
   PubMed Web of Science ®Google Scholar
• Baral, S., Beyrer, C., Muessig, K., Poteat, T., Wirtz, A. L., Decker, M. R., … Kerrigan, D. (2012). Burden of HIV among female sex workers in low-income and middle-income countries: A systematic review and meta-analysis. The Lancet Infectious Diseases, 12(7), 538–549. doi: 10.1016/S1473-3099(12)70066-X
   PubMed Web of Science ®Google Scholar
• Bekker, L.-G., Johnson, L., Cowan, F., Overs, C., Besada, D., Hillier, S., & Cates, W. (2015). Combination HIV prevention for female sex workers: What is the evidence? The Lancet, 385(9962), 72–87. doi: 10.1016/S0140-6736(14)60974-0
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2014). Preexposure prophylaxis for the prevention of HIV infection in the United States–2014: A clinical practice guideline. Atlanta, GA: Author.
   Google Scholar
• Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., … Kittimunkong, S. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir study): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 381(9883), 2083–2090. doi: 10.1016/S0140-6736(13)61127-7
   PubMed Web of Science ®Google Scholar
• Delany-Moretlwe, S., Mullick, S., Eakle, R., & Rees, H. (2016). Planning for HIV preexposure prophylaxis introduction: Lessons learned from contraception. Current Opinion in HIV and AIDS, 11(1), 87–93. doi: 10.1097/COH.0000000000000221
   PubMed Web of Science ®Google Scholar
• Eaton, L. A., Driffin, D. D., Smith, H., Conway-Washington, C., White, D., & Cherry, C. (2014). Psychosocial factors related to willingness to use pre-exposure prophylaxis for HIV prevention among Black men who have sex with men attending a community event. Sexual Health, 11(3), 244–251. doi: 10.1071/SH14022
   PubMed Web of Science ®Google Scholar
• Eisingerich, A. B., Wheelock, A., Gomez, G. B., Garnett, G. P., Dybul, M. R., & Piot, P. K. (2012). Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: A multinational study. PloS One, 7(1), e28238. doi: 10.1371/journal.pone.0028238
   PubMed Web of Science ®Google Scholar
• International Partnership for Microbicides. (2016). Two large studies show IPMs monthly vaginal ring helps protect women against HIV Retrieved from http://www.ipmglobal.org/publications/two-large-studies-show-ipm%E2%80%99s-monthly-vaginal-ring-helps-protect-women-against-hiv.
   Google Scholar
• Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., … Noguchi, L. (2015). Tenofovir-based preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 372(6), 509–518. doi: 10.1056/NEJMoa1402269
   PubMed Web of Science ®Google Scholar
• Paz-Bailey, G., Noble, M., Salo, K., & Tregear, S. J. (2016). Prevalence of HIV among US female sex workers: Systematic review and meta-analysis. AIDS and Behavior, 20(10), 2318–2331. doi: 10.1007/s10461-016-1332-y
   PubMed Web of Science ®Google Scholar
• Prüss-Ustün, A., Wolf, J., Driscoll, T., Degenhardt, L., Neira, M., & Calleja, J. M. G. (2013). HIV due to female sex work: Regional and global estimates. PloS One, 8(5), e63476. doi: 10.1371/journal.pone.0063476
   PubMed Web of Science ®Google Scholar
• Strathdee, S. A., & Stockman, J. K. (2010). Epidemiology of HIV among injecting and non-injecting drug users: Current trends and implications for interventions. Current HIV/AIDS Reports, 7(2), 99–106. doi: 10.1007/s11904-010-0043-7
   PubMedGoogle Scholar
• Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … Chillag, K. L. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434. doi: 10.1056/NEJMoa1110711
   PubMed Web of Science ®Google Scholar
• Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., … Onyango, J. (2012). Preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 367(5), 411–422. doi: 10.1056/NEJMoa1202614
   PubMed Web of Science ®Google Scholar
• Van der Elst, E. M., Mbogua, J., Operario, D., Mutua, G., Kuo, C., Mugo, P., … Priddy, F. (2013). High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: Qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS and Behavior, 17(6), 2162–2172. doi: 10.1007/s10461-012-0317-8
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV.
   Google Scholar
• Ye, L., Wei, S., Zou, Y., Yang, X., Abdullah, A. S., Zhong, X., … Wu, D. (2014). HIV pre-exposure prophylaxis interest among female sex workers in Guangxi, China. PloS One, 9(1), e86200. doi: 10.1371/journal.pone.0086200
   PubMed Web of Science ®Google Scholar